# Request for Information: Strategies to Develop a Single-Dose Vaccine for Pandemic Influenza

Canonical: https://abierto.us/opportunities/24prizerfi001

- Solicitation number: 24-PRIZE-RFI-001
- Notice type: Special notice
- Status: Closed. Deadline was August 5, 2024 at 4:59 PM EDT
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Barda - Aspr / Daappo / Barda DCMA (75A501)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AN42 Health R&D Services; Health Care - Other; Applied Research
- First posted: July 8, 2024
- Last posted: July 8, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/e926e139f2454b3a8c666546f9c9ff24/view

## Description

The Division of Research, Innovation and Ventures (DRIVe) of the Biomedical Advanced Research and Development Authority (BARDA), the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) is issuing this Request for Information (RFI) to solicit feedback from biopharmaceutical stakeholders and other vaccine development experts regarding strategies to develop a pandemic influenza vaccine that elicits robust and durable immunity following a single dose in humans. To view the full RFI, including the specific questions for which BARDA is seeking answers, please see the attached document.

## Publications

- July 8, 2024: Special notice, due August 5, 2024 at 4:59 PM EDT. Notice e926e139f2454b3a8c666546f9c9ff24. https://sam.gov/workspace/contract/opp/e926e139f2454b3a8c666546f9c9ff24/view

## Points of contact

- DRIVe, DRIVeComments@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/24prizerfi001.